Safal Herbs Financials

BSE: 532034

₹1.38

₹0.06 (4.55%)

As on 11-Mar-2020IST

Market cap

₹14 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

1.6

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Operating Revenue	0.34	--	0.10	0.34	1.77	1.41
Total Income	0.42	0.06	0.12	0.36	1.93	1.44
Total Expenditure	0.42	0.05	0.15	0.37	1.91	1.42
EBITDA	-0.09	-0.05	-0.05	-0.03	-0.13	-0.01
Depreciation	--	--	--	--	--	--
EBIT	-0.09	-0.05	-0.05	-0.03	-0.13	-0.01
Interest	--	0.00	0.00	0.00	0.00	0.00
Other Income	0.09	0.06	0.02	0.02	0.15	0.02
Exceptional Items	--	--	--	--	--	--
Profit before Tax	0.00	0.00	-0.03	-0.01	0.02	0.02
Provision for Tax	0.00	0.00	--	--	0.01	0.00
Profit after Tax	--	0.00	-0.03	-0.01	0.01	0.01

Liabilities (₹ Cr)	TTM	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Shareholder's Funds	8.95	8.95	8.94	8.98	8.99	8.98
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	--	--
Current Liabilities	0.01	0.01	0.06	0.18	0.01	0.31
Total Liabilities	8.96	8.96	9.00	9.16	9.01	9.29

Assets (₹ Cr)	TTM	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Non-Current Assets	--	--	--	--	--	4.00
Current Assets	8.85	8.82	8.86	9.02	8.87	5.15
Total Assets	8.96	8.96	9.00	9.16	9.01	9.29
Total Debt*	--	--	--	--	--	--
Net Current Assets	8.84	8.81	8.81	8.84	8.85	4.84
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Cash From Operating Activities	--	0.01	-0.02	0.00	-4.04	-0.01
Cash Flow from Investing Activities	--	--	--	--	4.00	--
Cash from Financing Activities	--	--	--	--	--	--
Net Cash Inflow / Outflow	--	0.01	-0.02	0.00	-0.04	-0.01

Financials Ratios	TTM	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Adjusted EPS (₹)	--	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	--	0.00	0.00	0.00	0.00	0.00
Adjusted Book Value (₹)	--	0.88	0.88	0.88	0.89	0.88
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.00	0.00	0.00	-0.40	0.00
Free Cash Flow per Share (₹)	--	0.00	0.00	0.00	-0.40	0.00

Profitability Ratios	TTM	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
ROCE (%)	--	0.03	-0.36	-0.16	0.23	0.18
ROE (%)	--	0.02	-0.36	-0.16	0.16	0.13
ROA (%)	--	0.02	-0.35	-0.15	0.15	0.12
EBIT Margin (%)	-25.30	--	-46.77	-10.01	-7.39	-0.58
Net Margin (%)	--	3.25	-27.79	-3.85	0.72	0.77
Cash Profit Margin (%)	--	--	-31.94	-4.08	0.79	0.79

Growth Ratios	TTM	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Revenue Growth (%)	11.26	-100.00	-70.38	-80.84	25.57	-1.76
EBIT Growth (%)	-226.92	-16.56	-38.32	74.04	-1,509.00	-120.23
Net Profit Growth (%)	--	105.83	-131.62	-199.59	25.22	-59.93
EPS Growth (%)	--	105.86	-128.57	-200.00	27.27	-96.04
Book Value Growth (%)	--	0.02	-0.38	-0.16	0.11	0.13

Valuation Ratios	TTM	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Price / Earnings	--	7,365.11	--	--	2,707.14	6,807.06
Price / Book Value	1.57	1.57	1.99	3.17	4.28	8.57
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	13,773.12	4,954.72	-545.49	-2,027.20	1,873.17	4,689.86
Close Price (₹)	--	1.38	1.75	2.80	3.79	7.58
High Price (₹)	--	2.16	2.80	4.00	7.58	44.15
Low Price (₹)	--	0.56	0.88	2.78	3.79	7.58
Market Cap (₹ Cr)	13.80	--	17.50	28.00	37.90	75.80

Solvency Ratios	TTM	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	1,474.50	859.67	160.53	49.32	684.17	16.86
Quick Ratio	1,474.50	859.67	160.53	49.32	684.17	16.86
Interest Coverage	--	11.22	-272.04	-149.94	549.37	498.38

Operating Efficiency Ratios	TTM	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Debtors to sales (%)	21.73	--	177.08	95.39	0.41	18.14
Asset Turnover	0.04	--	0.01	0.04	0.19	0.15
Receivable days	--	--	910.99	178.04	27.12	189.76
Inventory Days	--	--	--	--	--	--
Payable days	--	--	514.96	100.43	29.07	50.35
Cash Conversion Cycle	--	--	396.03	77.60	-1.94	139.41

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.